glp 1 and pancreatitis Updates in Medicine | GLP-1s may raise risk early—but over time, protective effects balance the scale, resulting in no increase in overall 1-year risk Understanding GLP-1 Agonists - YouTube

These include type 2 diabetes and prediabetes (because GLP-1 medications affect blood sugar), thyroid conditions (because of the boxed warning about medullary thyroid carcinoma), a history of pancreatitis (because GLP-1 medications carry a small risk of pancreatitis), gastroparesis or other gastric motility disorders (because GLP-1 medications slow gastric emptying), and any history of eating disorders (because the appetite-suppressing effects of GLP-1 medications require careful management in patients with disordered eating)

As a result, some worry that society is once again prioritising thinness as the ultimate beauty standard and propagating an unhealthy relationship with food despite years of progress toward body positivity and inclusivity

Then in April 2025, Pfizer announced the discontinuation of danuglipron itself after a case of potential drug-induced liver injury was identified in one participant during a dose-optimization study

doi: 10.1172/JCI57256 [DOI] [PMC free article] [PubMed] [Google Scholar] 225

GLP-1 also reduces meta-inflammation and has an inhibitory effect on leptin resistance

Prescription options like Wegovy prescription Chicago and Zepbound weight loss Chicago are backed by clinical research, making them a trusted choice within medical weight loss Chicago programs